Exhibitor Kits
News Releases
Oct 16, 2023
Mitsubishi Tanabe Pharma America Spotlights ALS Research at the XXVI World Congress of Neurology

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of five abstracts in amyotrophic lateral sclerosis (ALS) at the XXVI World Congress of Neurology (WCN), being held...

Oct 1, 2021
World's Leading Neuroscientists Unveil Research on COVID-19's Impact on the Brain, Understanding Migraine Pathophysiology, Solving the Mystery of Sleep, Biomarkers in Traumatic Brain Injury and More at 25th Biennial World Congress of Neurology from October 3-7

The impact COVID-19 has on the brain, understanding migraine pathophysiology, solving the mystery of sleep by "Lighting Up the Brain," blood biomarkers for traumatic brain injury and more...

Nov 19, 2019
Potential New Biomarkers for Parkinson's Disease Could Change Trajectory of Diagnosis and Treatment

World Federation of Neurology: A groundbreaking presentation coming out of the XXIV World Congress of Neurology (WCN 2019) in Dubai, UAE, highlighted several significant advances in Parkinson's...

Nov 18, 2019
Pregnancy No Longer Believed to Modify Trajectory of MS, Experts Say

World Federation of Neurology: November 18, 2019 | London — For women living with MS, pregnancy, and breastfeeding were once thought to slow the progression of the disease. During the XXIV World...

Nov 18, 2019
The Prognosis for MS is Changing Due to Advancements in Treatment and Awareness, Yet Access to Care is Top of Mind for Global Neurologists

World Federation of Neurology: November 18, 2019 | London— Are regulators keeping up with new treatments and management strategies that can greatly improve the lives of patients with multiple...

More »